Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

App aims to ease cancer treatment side effects

NCT ID NCT07642375

Symptom relief Sponsor: CareAcross Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a personalized online platform can help people with advanced sarcoma better manage side effects like fatigue, nausea, and pain. About 108 participants will be randomly assigned to receive either standard care or extra digital support. The goal is to see if those using the platform report fewer or less severe side effects over time.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
digital health platform with personalized educational and supportive materials
What this could lead to
If it works, this could show that a simple online tool helps people with advanced sarcoma feel better and manage treatment side effects more effectively.
What could go wrong
This is a small, early-stage study with only 108 participants and no blinding, so results may not apply broadly. The intervention is behavioral, not a drug, so any benefit is likely modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 108 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2023

Expected to finish

Feb 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age of ≥ 18 years. * Diagnosis of locally advanced or metastatic sarcoma of any location and origin. * Ability to understand and operate in a digital environment. * Patients planned to start standard of care treatment within the next month, or are currently undergoing standard of care treatment of any line. * Treatments include surgery, radiotherapy, chemotherapy, immunotherapy, targeted therapy, hormonal therapy, or any combination of the above. Exclusion Criteria: * Limited ability or willingness to report side-effects on an online platform. * Performance status \>3. * Life expectancy of \<6 months. * Participation in an interventional clinical trial with investigational drugs or devices.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Advanced sarcoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

sarcoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Advanced sarcoma Metastatic sarcoma

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    11 sites. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • 251 Air Force General Hospital

    RECRUITING

    Athens, 11527, Greece

  • 401 General Military Hospital

    RECRUITING

    Athens, 11525, Greece

  • Attikon Hospital, 2nd clinic

    RECRUITING

    Athens, 12461, Greece

  • Attikon Hospital, 4th clinic

    RECRUITING

    Athens, 12461, Greece

  • Bioclinic

    RECRUITING

    Thessaloniki, 54622, Greece

  • Hygeia hospital

    RECRUITING

    Athens, 15123, Greece

    Contact Email: •••••@•••••

  • Ippokrateio General Hospital

    RECRUITING

    Athens, Greece, Greece

  • Ippokratio General Hospital of Thessaloniki

    RECRUITING

    Thessaloniki, 54642, Greece

  • Metropolitan General Hospital

    RECRUITING

    Athens, 15562, Greece

    Contact Email: •••••@•••••

  • Mitera hospital

    RECRUITING

    Athens, 15123, Greece

    Contact Email: •••••@•••••

  • Papageorgiou General Hospital

    RECRUITING

    Thessaloniki, 56403, Greece

More trials for these conditions

Other studies related to the condition(s) this trial covers.